Use of Pedometer Following Radical Prostatectomy
Prostate Cancer, Ambulation Difficulty
About this trial
This is an interventional other trial for Prostate Cancer focused on measuring radical prostatectomy, pedometer, return of bowel function, post-operative narcotic use
Eligibility Criteria
Inclusion Criteria:
This study will include men 18-75 undergoing robot-assisted laparoscopic radical prostatectomy for prostate cancer at Virginia Mason Medical Center.
Exclusion Criteria:
- Long-term opioid use, defined by CDC as use of opioids on most days for >3 months
- History of inflammatory bowel disease
- Prior abdominopelvic radiation
- Travel to Europe during study period
- Concurrent surgery during radical prostatectomy
- Inability to ambulate
- Gastroparesis or other baseline bowel dysmotility issues
- Inability or unwillingness of subject or legal guardian/representative to give written informed consent.
Sites / Locations
- Virginia Mason Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Pedometer group
Control group
This group will be given a pedometer following radical prostatectomy. Subjects in the experimental group will have a graduated step-count goal as follows: POD 0-2: 2,000/day. POD 3-6: 3,000/day. POD 7-9: 4,000/day. POD 10-14: 5,000/day.
This is the control group. Following radical prostatectomy, subjects in the control group will receive standard of care, which includes counseling regarding the importance of ambulation following surgery.